Keyword Analysis & Research: replication competent aav
Keyword Research: People who searched replication competent aav also searched
Search Results related to replication competent aav on Search Engine
-
Cellular, Tissue, and Gene Therapies Advisory Committee …
https://www.fda.gov/media/151599/download
Webreplicase proteins that are required for AAV replication and packaging of the genome in the capsid. The ITRs are also essential for replication and packaging and form hairpin-like structures.
DA: 52 PA: 98 MOZ Rank: 84
-
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548848/
WebJul 1, 2017 · Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies.
DA: 71 PA: 12 MOZ Rank: 35
-
Identification and elimination of replication-competent adeno
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC191962/
WebAbstract. Adeno-associated virus (AAV) vector preparations are often contaminated with variable amounts of replication-competent AAV (rcAAV), which may influence the behavior of these vectors both in cultured cells and in animals. A packaging plasmid/vector plasmid system containing no significant homology and lacking the wild-type AAV p5 ...
DA: 88 PA: 18 MOZ Rank: 5
-
Meeting FDA Guidance recommendations for replication-competent …
https://www.sciencedirect.com/science/article/pii/S2329050122001681
WebMar 9, 2023 · The assay needs to be tailored for the parent virus (e.g., MLV, HIV-1) and vector pseudotype (envelope). The FDA has recommended a minimum of five cell passages (approximately 3 weeks) of culture to identify slow-growing viruses. Table 1 provides a list of detection methods used in RCR assays.
DA: 73 PA: 75 MOZ Rank: 50
-
Identification and elimination of replication-competent adeno
https://pubmed.ncbi.nlm.nih.gov/9261406/
WebAbstract. Adeno-associated virus (AAV) vector preparations are often contaminated with variable amounts of replication-competent AAV (rcAAV), which may influence the behavior of these vectors both in cultured cells and in animals.
DA: 79 PA: 82 MOZ Rank: 31
-
Replication competent helper functions for recombinant AAV …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638078/
WebReplication competent AAV determination. The titer of wild-type AAV or replication competent AAV was determined by serial dilution of 2 μl cell lysate and infecting 293 cells in the absence or presence of adenovirus infection at MOI of 5. The total cellular DNA was isolated 48 h after infection.
DA: 55 PA: 98 MOZ Rank: 25
-
Adeno-associated virus as a delivery vector for gene therapy
https://www.nature.com/articles/s41392-024-01780-w
WebApr 3, 2024 · AAVone yields higher rAAV production compared to the triple transfection method, with lower batch-to-batch variations and reduced levels of replication-competent AAV (rcAAV).
DA: 6 PA: 85 MOZ Rank: 75
-
Querying Recombination Junctions of Replication-Competent …
https://pubmed.ncbi.nlm.nih.gov/37376529/
WebMay 24, 2023 · One type of contaminant that remains poorly investigated is replication-competent (rc)AAVs. rcAAVs form through recombination of DNA originating from production materials, yielding intact, replicative, and potentially infectious virus-like virions.
DA: 47 PA: 10 MOZ Rank: 62
-
Development of an Inducible, Replication-Competent Assay Cell …
https://pubmed.ncbi.nlm.nih.gov/36565023/
WebFeb 1, 2024 · Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors. Hum Gene Ther. 2023 Feb;34 (3-4):162-170. doi: 10.1089/hum.2022.001. Authors. Zion Lee 1 , Min Lu 1 , Eesha Irfanullah 1 , Morgan Soukup 1 , Daniel Schmidt 1 2 , Wei-Shou Hu 1. Affiliations.
DA: 74 PA: 70 MOZ Rank: 60
-
Replication-Competent AAV Testing - Creative Biogene
https://www.creative-biogene.com/Services/Custom-Viral-Service/Replication-Competent-AAV-Testing.html
WebReplication-incompetent vector particles derived from AAV (adeno-associated virus) have been shown to mediate transfer and expression of heterologous genes (transgenes) into a variety of cells in vivo and in vitro. It has tremendous potential in both research and therapeutic applications.
DA: 25 PA: 14 MOZ Rank: 16